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Abdominal aortic aneurysms 
Abdominal aortic aneurysms (AAA) are defined as an infrarenal increase in aortic 
diameter 1.5 times the normal diameter or an absolute diameter of > 3 cm.1 Loss 
of elastin, increased inflammation and smooth muscle cell apoptosis appear to be 
the main causes for dilatation of all layers in the aortic wall, although the precise 
pathways are still unclear.2,3 Most important risk factors for developing AAAs are 
male gender, age, family history, and smoking.4 Abdominal aortic aneurysm is 
present in approximately 2% of the global population. 
AAAs are mostly asymptomatic and are incidental findings on computed 
tomography angiography (CTA) or ultrasound. As the diameter of AAAs increases, 
the risk of rupture raises. Rupture is associated with a mortality rate up to 65-
85%, and these ruptures account for a significant part of deaths, especially among 
men.5-7 So, intervention is needed when risk of rupture exceeds the risk of the 
procedure. For AAA this crossover point is roughly estimated at a diameter of 55 
mm for men and 52 mm for women, or > 10 mm growth per year.8 However, 
every indication for AAA repair should be individually based.  
 
Endovascular Aneurysm Repair (EVAR) 
Besides open repair, AAAs can be treated with endovascular aneurysm repair 
(EVAR). EVAR was introduced by Volodos et al.9 in 1988, and since then several 
generations of endografts have been developed to improve the sustainability and 
decrease the risk of complications of EVAR. 
During the EVAR procedure a main body (prepared in a delivery system) is 
inserted into the left or right common femoral artery and positioned at the landing 
zone (infrarenal aortic neck). For infrarenal AAAs the landing zone is just below 
the orifice of the lowest renal artery. Sealing will be achieved by oversizing of the 
diameter of the endograft compared to the diameter of the infrarenal aorta (radial 
force), and in the majority of the endografts with anchoring pins in the suprarenal 
bare stent. If the main body is positioned correctly the delivery sheath is 
withdrawn, and the endoprosthesis is unfolded and bilateral limbs are inserted 
through the common femoral arteries into the main body, with distal sealing in 
the common iliac arteries, thereby excluding the aneurysm from the blood flow.  
Compared to open repair, EVAR has been associated with a lower 30-day mortality 
rate. However, a two-fold higher reintervention rate is required during follow-up 
compared to open repair.10,11 Especially type Ia and Ib endoleaks (proximal and 
distal leakage between aortic wall/ iliac arteries and endograft, respectively), type 
III (leakage due to inadequate fixation between graft components, or fabric tears) 




to the persistent pressure in the aneurysm sac.12 During long-term follow-up 2.3 
- 3.1% of all EVAR cases develop type Ia endoleaks. Migration occurs in 1.0 to 
5.1% of all EVARs, while type Ib endoleak occurs in 2.3%.13-17  
Preoperative anatomical risk factors associated with these complications are short 
infrarenal necks (<1 cm), large supra- and infrarenal angulations (>75°), and 
large neck diameter (>28 mm).18-25 Careful pre-operative planning may reduce 
the risk of post-EVAR complications. However, late type Ia endoleaks and 
migration are a result of insufficient seal and fixation in the aortic neck, and 
development of the disease. These factors cannot always be addressed during the 
procedure, and may arise during follow-up. There is need for a measuring tool 
that can forecast sealing complications by assessing small changes in sealing and 
position during follow-up.  Ideally, seal failure can be prevented and reintervention 
can be performed before urgent complications occur. Moreover, this can also be 




If a seal complication has occurred the Heli-FX EndoAnchor System (Medtronic 
Vascular, Santa Rosa, CA, USA) can be used therapeutically to resolve type Ia 
endoleaks or prevent persistent migration of the endograft.26 EndoAnchors can 
also be used prophylactically in patients with challenging neck anatomy.27,28 The 
4.5 mm long by 3.5 mm diameter helical design of the EndoAnchors ensures safe 
attachment of the endograft to the aortic wall and the cross bar at the end of each 
EndoAnchor prevents over-penetration (Figure 1.1).28 The EndoAnchors increase 
the fixation strength to that of a surgical hand-sewn anastomosis when they are 
deployed circumferential into the aortic wall.29 This can only be achieved when the 
EndoAnchor implants successfully penetrate the aortic wall with 2 mm.30,31 Studies 
have shown good outcomes in both prophylactic and therapeutic use of the 
EndoAnchors. Large patient cohorts and clinical outcomes were analysed in the 
ANCHOR registry26-28,31-34, however, no data is yet available on individual 
EndoAnchor penetration and the sustainability of these individual penetrating 
EndoAnchors.  
  
Endovascular Aneurysm Sealing (EVAS) 
In 2013 endovascular aneurysm sealing (EVAS) was introduced with the Nellix 
endosystem (Endologix Inc, Irvine, CA, USA). EVAS as alternative for EVAR may 
increase the number of patients eligible for endovascular repair, as the 





Figure 1.1: Axial view of the aortic lumen with an endograft on a computed tomography 




Nellix endosystem contains of two balloon-expanding cobalt-chromium stent 
frames which are 10-mm in diameter.36 These stent frames provide blood supply 
to the iliac arteries and are surrounded by endobags which are filled with 
polyethylene glycol (PEG) during the EVAS procedure. The PEG polymerizates in 
3-5 minutes after insertion into the endobags, occupying the aneurysm cavity  and 
therefore excluding the aneurysm from the blood flow. For determination of the 
volume of PEG used to occupy the aneurysm cavity, the aneurysm diameter, 
length and the volume of intraluminal thrombus (ILT) should be accounted for. 
ILT is present in 75% of the AAAs.37 The proximal uncovered stent of the 
stentframes must be deployed 5 mm above the lower border of the orifice of the 
lowest renal artery, for total seal of the endobags in the aortic neck. This sac-
anchoring system is thought to reduce endoleaks and migration. The early results 
were promising, but limited to 30 days and one-year results.38-40 At mid-term 
follow-up differences in clinical outcome have been observed, questioning the 
durability of the EVAS device as endoleaks and migration occurred.41,42 Further 
insight is needed in the behaviour and sustainability of the Nellix endosystem in 
the abdominal aorta. Moreover, risk factors that cause complications need to be 
defined. 
 




The overall goals of this thesis are to investigate technologies for improved 
detection and prevention of EVAR complications and to investigate the occurrence 
of complications after EVAS. The thesis consists of two parts: 
 
Technologies for detection and prevention of complications after Endovascular 
Aneurysm Repair (EVAR): 
o Part IA; The first objective of the thesis is to introduce a new 3D 
methodology for determination of the position and apposition of 
endografts in the abdominal and thoracic aorta.  
 
o Part IB; The second objective is to associate positional EndoAnchor 
characteristics with successful penetration of EndoAnchors.  
 
Complications after Endovascular Aneurysm Sealing (EVAS): 
o Part II; The third objective is to associate complications after EVAS with 
mechanical behaviour of ILT, arterial stiffness and positioning of the Nellix 
endosystem. Moreover, predictive anatomical characteristics for the 
occurrence of complications are determined.  
 
Outline of the thesis 
In Part IA the newly developed 3D methodology to identify patients at risk for 
sealing complications after EVAR is introduced (Chapter two). The new software 
is also validated for TEVAR in Chapter three. The new methodology is used for 
precise determination of the position and the apposition of EVAR devices. By 
monitoring these locations and surfaces early changes in endograft position and 
seal may forecast late complications.  
 
These chapters focus on answering the following questions: 
x How should subtle changes in the endograft position and 
apposition in the infrarenal neck during CT follow-up be 
interpreted? (Chapter two) 
x How should subtle changes in the proximal and distal sealing 
zones in thoracic endograft position and apposition during CT 
follow-up be interpreted? (Chapter three) 
 
In Part IB individual EndoAnchor deployment success is studied thoroughly. 
EndoAnchors are designed to increase migration resistance and apposition of 




implants are investigated regarding penetration depths as well as angles and 
circumferential distribution over the aortic circumference after therapeutic use to 
treat type IA endoleaks. In Chapter five the sustainability of these EndoAnchor 
implants is investigated.  
 
These chapters focus on answering the following research questions: 
x What is the association between EndoAnchor deployment and 
successful resolving of type IA endoleaks, considering their 
distribution along the circumference of the neck, penetration 
depth into the aortic wall, and angle of penetration? (Chapter 
four) 
x What is the sustainability of initially successfully penetrating 
EndoAnchors during follow-up? (Chapter five) 
 
Part II focusses on causes of complications after EVAS. First (Chapter six), a 
study was performed on fluid displacement during compression on intraluminal 
thrombus. It is hypothesized that during pressurization the volume of intraluminal 
thrombus may decrease, due to squeezing liquid out of the thrombus. This may 
have negative effects on the stability of the endobags of the Nellix endosystem. 
In this study freshly harvested ILT was inserted into a compression set-up, to 
investigate the fluid displacement under pressure.  
Aortic pulse wave velocity (aPWV) is a measure for arterial stiffness, which is 
associated with increased cardiovascular risk.43 In Chapter seven the aPWVs for 
an EVAS configuration, two EVAR configurations, and a tube graft in an in-vitro 
aortoiliac trajectory were calculated, to investigate the influence of different aortic 
endoprostheses on aPWV and structural stiffness. Chapter eight introduces a 
method to investigate the EVAS stentframe displacement over time within the 
aneurysm. In Chapter nine the non-apposition surface was introduced in a study 
on the accuracy in positioning the EVAS system, as the surface over the aortic 
wall between the renal arties and the top of the endobags. Ideally this non-
apposition surface is zero. The endobags of the EVAS system do not have 
radiopaque markers on the endobags, therefore, positioning the endobags just 
below the renal arteries may be difficult. In Chapter ten the anatomical 
characteristics of 261 EVAS patients treated in three high volume EVAS centers 
are determined and used in a regression analysis to find anatomical predictors for 
complication after EVAS. 
 




x What is the quantity of fluid displacement from freshly harvested 
intraluminal thrombus when uniform compression is applied in an 
in vitro compression set-up? (Chapter six) 
x What influence do different endograft configurations have on 
aortic pulse wave velocity and structural stiffness in an in-vitro 
aortic model? (Chapter seven) 
x How precise can three-dimensional positions of the Nellix stent 
frame and changes in position be determined? (Chapter eight) 
x What is the accuracy of initial position and seal of the Nellix EVAS 
system in the aortic neck using a novel measurement 
methodology? (Chapter nine) 
x What preoperative anatomical aortic characteristics are predictive 
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